Standard & Poor’s Ratings Services announced that it has affirmed its ‘A-‘ counterparty credit and financial strength ratings and negative outlook on Amedex Insurance Co.
S&P then said that it had withdrawn the ratings at the company’s request.
“The ratings reflected Amedex’s good business position as a niche provider of major medical products in Latin America, favorable operating performance, and strong capitalization,” said S&P.
“These positive factors are offset by Amedex’s limited size, declining enrollment trends, new business risk through Amedex Bermuda, and high operating expenses, which are the direct consequence of its target market and high level of service provided,” the announcement concluded.
Was this article valuable?
Here are more articles you may enjoy.
Three Sentenced in Bear-Suit Attacks Insurance Fraud Case 
Business Interruption Claims Arising From the Middle East Conflict 
Florida Sunshine: Big Improvement in Combined Ratio in 2025, Gallagher Says 
Claim Severity Trends for Medical Malpractice ‘Stand Out’: S&P GMI 
